News Conference News AHA 2017 ‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18 Michael O'Riordan November 15, 2017
News Conference News TCT 2017 No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS Michael O'Riordan October 30, 2017
News Conference News TCT 2017 DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis Todd Neale October 30, 2017
News Conference News TCT 2017 Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year Yael L. Maxwell October 30, 2017
News Conference News TCT 2017 No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy Michael O'Riordan October 30, 2017
News Conference News ESC 2017 Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART Shelley Wood August 27, 2017
News Industry News Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent July 25, 2017
News Conference News SCAI 2017 Bioresorbable Scaffolds: Where Do We Go From Here? L.A. McKeown May 15, 2017
Presentation SCAI 2017 Long-term outcomes of Bioresorbable Vascular Scaffolds Presenter: Roxana Mehran May 13, 2017
News Industry News Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes May 02, 2017
News Conference News ACC 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017
News Daily News Women Without Diabetes Fare as Poorly as Diabetic Men Post-PCI L.A. McKeown January 30, 2017
Presentation CCVVC 2016 Optimal Duration of DAPT: Update on DAPT Guidelines Presenter: Roxana Mehran June 16, 2016